Apyx Medical Corporation APYX Proceeds From Issuance Of Common Stock And Warrants
Proceeds From Issuance Of Common Stock And Warrants at other companies
Other financials
Where this comes from
Reported directly by Apyx Medical Corporation in its filing.
Tagged under the XBRL concept apyx:ProceedsFromIssuanceOfCommonStockAndWarrants.
The official record: Apyx Medical Corporation’s 10-K, filed March 10, 2026, on SEC EDGAR. View the filing →
Ask your AI about Apyx Medical Corporation's proceeds from issuance of common stock and warrants.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Apyx Medical Corporation's proceeds from issuance of common stock and warrants?
- Apyx Medical Corporation (APYX) reported proceeds from issuance of common stock and warrants of $2.33M in Q4 2025.
- How has Apyx Medical Corporation's proceeds from issuance of common stock and warrants changed year-over-year?
- Apyx Medical Corporation's proceeds from issuance of common stock and warrants increased by 32.9% year-over-year, from $1.75M to $2.33M.
- What does proceeds from issuance of common stock and warrants mean?
- This metric measures the total cash inflows generated from the sale of common equity shares and associated warrants to investors. It serves as a primary indicator of the company's ability to raise external capital to fund operations or growth initiatives. Frequent reliance on this source may indicate a need for dilution to support liquidity.